Akari Therapeutics PLC/ US00972G2075 /
2024-04-22 9:46:53 PM | Chg. +0.0138 | Volume | Bid1:24:05 AM | Ask1:24:05 AM | High | Low |
---|---|---|---|---|---|---|
1.1800USD | +1.18% | 13,919 Turnover: 15,538.6260 |
1.0000Bid Size: 2,500 | 1.3000Ask Size: 200 | 1.2200 | 1.1300 |
GlobeNewswire
04-15
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
GlobeNewswire
04-01
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
GlobeNewswire
03-15
SHAREHOLDER ALERT: The M&A Class Action Launches Investigation of the Merger – SDPI, MINM, SCX, AKTX
GlobeNewswire
03-05
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expande...
GlobeNewswire
03-05
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expande...
GlobeNewswire
01-02
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Pla...
GlobeNewswire
2023-12-01
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of ...
GlobeNewswire
2023-11-16
Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomaco...
GlobeNewswire
2023-11-06
Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a...
GlobeNewswire
2023-10-04
Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now
GlobeNewswire
2023-10-03
Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now
GlobeNewswire
2023-09-29
Akari Therapeutics Reports First Half 2023 Financial Results and Highlights
GlobeNewswire
2023-09-21
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Pla...
GlobeNewswire
2023-09-19
Akari Therapeutics to Host Key Opinion Leader Webinar on Hematopoietic Stem Cell Transplant-Related ...
GlobeNewswire
2023-09-05
Akari Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
2023-08-18
Akari Therapeutics Announces Establishment of Boston U.S. Headquarters Office to Support Expanding O...
GlobeNewswire
2022-03-21
Akari Therapeutics to Present on Two Ongoing Programs Covering Age-Related Macular Degeneration and ...
GlobeNewswire
2022-03-02
Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer